Skip to main content
Caplight Logo









PhageNova Bio, Inc.

PhageNova Bio, Inc.

Private
Summit, New JerseyHealthcare & Life Scienceshttps://phagenovabio.com/

Company Overview

PhageNova Bio, Inc. is a biotechnology company that develops a gene-therapy-based platform combining bacteriophage targeting with adeno-associated virus gene expression for cancer and vaccine applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

gene deliveryAAVPadeno-associated virusbacteriophagetargeted therapygene therapyoncologyvaccine platformvector platformsolid tumorsbiotechdrug discoveryprecision medicinephage therapyviral vector

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhageNova Bio, Inc. Comparables

Compare PhageNova Bio, Inc. with similar companies based on industry and business-model similarity.

PhageNova Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Siren Biotechnology
82%
LyseNTech
72%
Coastar Therapeutics
72%

PhageNova Bio, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

PhageNova Bio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PhageNova Bio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PhageNova Bio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSummit, New Jersey
Employee Range1
Year Founded2012
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?